149 related articles for article (PubMed ID: 16802767)
1. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study.
Becker AB; Kuznetsova O; Vermeulen J; Soto-Quiros ME; Young B; Reiss TF; Dass SB; Knorr BA;
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):800-7. PubMed ID: 16802767
[TBL] [Abstract][Full Text] [Related]
2. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
Pedersen S; Agertoft L; Williams-Herman D; Kuznetsova O; Reiss TF; Knorr B; Dass SB; Wolthers OD
Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605
[TBL] [Abstract][Full Text] [Related]
4. Montelukast: a review of its therapeutic potential in persistent asthma.
Jarvis B; Markham A
Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
[TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
6. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
[TBL] [Abstract][Full Text] [Related]
7. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
[TBL] [Abstract][Full Text] [Related]
8. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
Baumgartner RA; Martinez G; Edelman JM; Rodriguez Gomez GG; Bernstein M; Bird S; Angner R; Polis A; Dass SB; Lu S; Reiss TF;
Eur Respir J; 2003 Jan; 21(1):123-8. PubMed ID: 12570120
[TBL] [Abstract][Full Text] [Related]
9. Effects of montelukast and beclomethasone on airway function and asthma control.
Israel E; Chervinsky PS; Friedman B; Van Bavel J; Skalky CS; Ghannam AF; Bird SR; Edelman JM
J Allergy Clin Immunol; 2002 Dec; 110(6):847-54. PubMed ID: 12464949
[TBL] [Abstract][Full Text] [Related]
10. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
11. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
12. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
[TBL] [Abstract][Full Text] [Related]
13. Spotlight on montelukast in asthma in children 2 to 14 years of age.
Muijsers RB; Noble S
Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
[TBL] [Abstract][Full Text] [Related]
14. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
15. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
[TBL] [Abstract][Full Text] [Related]
16. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
Knorr B; Matz J; Bernstein JA; Nguyen H; Seidenberg BC; Reiss TF; Becker A
JAMA; 1998 Apr; 279(15):1181-6. PubMed ID: 9555757
[TBL] [Abstract][Full Text] [Related]
17. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
Muijsers RB; Noble S
Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
[TBL] [Abstract][Full Text] [Related]
18. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
19. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma.
Volovitz B; Tabachnik E; Nussinovitch M; Shtaif B; Blau H; Gil-Ad I; Weizman A; Varsano I
J Allergy Clin Immunol; 1999 Dec; 104(6):1162-7. PubMed ID: 10588996
[TBL] [Abstract][Full Text] [Related]
20. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]